nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR7—vein—ovarian cancer	0.0358	0.153	CbGeAlD
Methysergide—HTR2A—vein—ovarian cancer	0.0223	0.0954	CbGeAlD
Methysergide—HTR1E—myometrium—ovarian cancer	0.0193	0.0825	CbGeAlD
Methysergide—HTR1E—female gonad—ovarian cancer	0.0102	0.0438	CbGeAlD
Methysergide—SIGMAR1—myometrium—ovarian cancer	0.00824	0.0352	CbGeAlD
Methysergide—HTR2B—myometrium—ovarian cancer	0.00822	0.0352	CbGeAlD
Methysergide—SIGMAR1—uterine cervix—ovarian cancer	0.00641	0.0274	CbGeAlD
Methysergide—HTR2B—uterine cervix—ovarian cancer	0.00639	0.0274	CbGeAlD
Methysergide—SIGMAR1—decidua—ovarian cancer	0.00611	0.0261	CbGeAlD
Methysergide—HTR2B—decidua—ovarian cancer	0.00609	0.0261	CbGeAlD
Methysergide—SIGMAR1—endometrium—ovarian cancer	0.0058	0.0248	CbGeAlD
Methysergide—HTR2B—endometrium—ovarian cancer	0.00578	0.0247	CbGeAlD
Methysergide—HTR7—epithelium—ovarian cancer	0.00552	0.0236	CbGeAlD
Methysergide—SIGMAR1—uterus—ovarian cancer	0.00534	0.0229	CbGeAlD
Methysergide—HTR2B—uterus—ovarian cancer	0.00533	0.0228	CbGeAlD
Methysergide—HTR1B—female reproductive system—ovarian cancer	0.00532	0.0228	CbGeAlD
Methysergide—HTR1D—female reproductive system—ovarian cancer	0.00515	0.022	CbGeAlD
Methysergide—HTR2C—female reproductive system—ovarian cancer	0.0051	0.0218	CbGeAlD
Methysergide—HTR2B—female reproductive system—ovarian cancer	0.00479	0.0205	CbGeAlD
Methysergide—HTR7—gonad—ovarian cancer	0.00459	0.0197	CbGeAlD
Methysergide—SIGMAR1—bone marrow—ovarian cancer	0.00453	0.0194	CbGeAlD
Methysergide—SIGMAR1—female gonad—ovarian cancer	0.00437	0.0187	CbGeAlD
Methysergide—SIGMAR1—vagina—ovarian cancer	0.00434	0.0186	CbGeAlD
Methysergide—HTR2B—vagina—ovarian cancer	0.00433	0.0185	CbGeAlD
Methysergide—HTR2A—embryo—ovarian cancer	0.00422	0.0181	CbGeAlD
Methysergide—HTR7—female reproductive system—ovarian cancer	0.0041	0.0176	CbGeAlD
Methysergide—SIGMAR1—testis—ovarian cancer	0.00388	0.0166	CbGeAlD
Methysergide—HTR2A—epithelium—ovarian cancer	0.00344	0.0147	CbGeAlD
Methysergide—HTR7—testis—ovarian cancer	0.00331	0.0142	CbGeAlD
Methysergide—Convulsion—Melphalan—ovarian cancer	0.00313	0.00411	CcSEcCtD
Methysergide—Discomfort—Topotecan—ovarian cancer	0.0031	0.00408	CcSEcCtD
Methysergide—Chest pain—Melphalan—ovarian cancer	0.00307	0.00404	CcSEcCtD
Methysergide—Myalgia—Melphalan—ovarian cancer	0.00307	0.00404	CcSEcCtD
Methysergide—Back pain—Vinorelbine—ovarian cancer	0.00305	0.00401	CcSEcCtD
Methysergide—Oliguria—Epirubicin—ovarian cancer	0.00301	0.00396	CcSEcCtD
Methysergide—Pain in extremity—Docetaxel—ovarian cancer	0.00299	0.00393	CcSEcCtD
Methysergide—Dyspepsia—Chlorambucil—ovarian cancer	0.00298	0.00391	CcSEcCtD
Methysergide—Oedema—Melphalan—ovarian cancer	0.00295	0.00387	CcSEcCtD
Methysergide—Thrombocytopenia—Topotecan—ovarian cancer	0.00295	0.00387	CcSEcCtD
Methysergide—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00293	0.00385	CcSEcCtD
Methysergide—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00292	0.00384	CcSEcCtD
Methysergide—Fatigue—Chlorambucil—ovarian cancer	0.00291	0.00383	CcSEcCtD
Methysergide—Pain—Chlorambucil—ovarian cancer	0.00289	0.0038	CcSEcCtD
Methysergide—Thrombocytopenia—Melphalan—ovarian cancer	0.00289	0.00379	CcSEcCtD
Methysergide—Tachycardia—Melphalan—ovarian cancer	0.00288	0.00378	CcSEcCtD
Methysergide—HTR2A—gonad—ovarian cancer	0.00286	0.0123	CbGeAlD
Methysergide—Dysuria—Paclitaxel—ovarian cancer	0.00285	0.00374	CcSEcCtD
Methysergide—Neutropenia—Paclitaxel—ovarian cancer	0.00285	0.00374	CcSEcCtD
Methysergide—Malaise—Vinorelbine—ovarian cancer	0.00284	0.00374	CcSEcCtD
Methysergide—SIGMAR1—lymph node—ovarian cancer	0.00281	0.012	CbGeAlD
Methysergide—Ataxia—Docetaxel—ovarian cancer	0.00281	0.00369	CcSEcCtD
Methysergide—HTR2B—lymph node—ovarian cancer	0.0028	0.012	CbGeAlD
Methysergide—Oliguria—Doxorubicin—ovarian cancer	0.00279	0.00366	CcSEcCtD
Methysergide—Feeling abnormal—Chlorambucil—ovarian cancer	0.00279	0.00366	CcSEcCtD
Methysergide—Weight increased—Paclitaxel—ovarian cancer	0.00277	0.00364	CcSEcCtD
Methysergide—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00276	0.00363	CcSEcCtD
Methysergide—Weight decreased—Paclitaxel—ovarian cancer	0.00275	0.00362	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00274	0.0036	CcSEcCtD
Methysergide—Orthostatic hypotension—Docetaxel—ovarian cancer	0.00273	0.00359	CcSEcCtD
Methysergide—Paraesthesia—Topotecan—ovarian cancer	0.0027	0.00355	CcSEcCtD
Methysergide—Chest pain—Vinorelbine—ovarian cancer	0.00269	0.00353	CcSEcCtD
Methysergide—Arthralgia—Vinorelbine—ovarian cancer	0.00269	0.00353	CcSEcCtD
Methysergide—Myalgia—Vinorelbine—ovarian cancer	0.00269	0.00353	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00268	0.00353	CcSEcCtD
Methysergide—Dyspnoea—Topotecan—ovarian cancer	0.00268	0.00353	CcSEcCtD
Methysergide—Abdominal pain—Chlorambucil—ovarian cancer	0.00267	0.00351	CcSEcCtD
Methysergide—Body temperature increased—Chlorambucil—ovarian cancer	0.00267	0.00351	CcSEcCtD
Methysergide—Discomfort—Vinorelbine—ovarian cancer	0.00265	0.00349	CcSEcCtD
Methysergide—Dyspepsia—Topotecan—ovarian cancer	0.00265	0.00348	CcSEcCtD
Methysergide—Paraesthesia—Melphalan—ovarian cancer	0.00265	0.00348	CcSEcCtD
Methysergide—Ergonovine—ABCB1—ovarian cancer	0.00264	0.475	CrCbGaD
Methysergide—Dyspnoea—Melphalan—ovarian cancer	0.00263	0.00345	CcSEcCtD
Methysergide—Blood urea increased—Epirubicin—ovarian cancer	0.00262	0.00344	CcSEcCtD
Methysergide—Gastrointestinal disorder—Topotecan—ovarian cancer	0.0026	0.00342	CcSEcCtD
Methysergide—Fatigue—Topotecan—ovarian cancer	0.00259	0.00341	CcSEcCtD
Methysergide—Dyspepsia—Melphalan—ovarian cancer	0.00259	0.00341	CcSEcCtD
Methysergide—Constipation—Topotecan—ovarian cancer	0.00257	0.00338	CcSEcCtD
Methysergide—Pain—Topotecan—ovarian cancer	0.00257	0.00338	CcSEcCtD
Methysergide—HTR2A—female reproductive system—ovarian cancer	0.00256	0.0109	CbGeAlD
Methysergide—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00254	0.00334	CcSEcCtD
Methysergide—Fatigue—Melphalan—ovarian cancer	0.00254	0.00334	CcSEcCtD
Methysergide—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00252	0.00331	CcSEcCtD
Methysergide—Pain—Melphalan—ovarian cancer	0.00252	0.00331	CcSEcCtD
Methysergide—Tachycardia—Vinorelbine—ovarian cancer	0.00251	0.0033	CcSEcCtD
Methysergide—Feeling abnormal—Topotecan—ovarian cancer	0.00248	0.00326	CcSEcCtD
Methysergide—Gastrointestinal pain—Topotecan—ovarian cancer	0.00246	0.00323	CcSEcCtD
Methysergide—Asthenia—Chlorambucil—ovarian cancer	0.00243	0.00319	CcSEcCtD
Methysergide—Blood urea increased—Doxorubicin—ovarian cancer	0.00242	0.00319	CcSEcCtD
Methysergide—Neutropenia—Docetaxel—ovarian cancer	0.00241	0.00317	CcSEcCtD
Methysergide—Oedema peripheral—Paclitaxel—ovarian cancer	0.0024	0.00316	CcSEcCtD
Methysergide—Abdominal pain—Topotecan—ovarian cancer	0.00238	0.00313	CcSEcCtD
Methysergide—Body temperature increased—Topotecan—ovarian cancer	0.00238	0.00313	CcSEcCtD
Methysergide—Weight increased—Docetaxel—ovarian cancer	0.00235	0.00309	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00235	0.00308	CcSEcCtD
Methysergide—Weight decreased—Docetaxel—ovarian cancer	0.00234	0.00307	CcSEcCtD
Methysergide—Thrombophlebitis—Epirubicin—ovarian cancer	0.00233	0.00306	CcSEcCtD
Methysergide—HTR2A—vagina—ovarian cancer	0.00231	0.0099	CbGeAlD
Methysergide—Diarrhoea—Chlorambucil—ovarian cancer	0.00231	0.00304	CcSEcCtD
Methysergide—Paraesthesia—Vinorelbine—ovarian cancer	0.00231	0.00304	CcSEcCtD
Methysergide—Dyspnoea—Vinorelbine—ovarian cancer	0.0023	0.00302	CcSEcCtD
Methysergide—Flushing—Paclitaxel—ovarian cancer	0.00226	0.00297	CcSEcCtD
Methysergide—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00222	0.00292	CcSEcCtD
Methysergide—Fatigue—Vinorelbine—ovarian cancer	0.00222	0.00292	CcSEcCtD
Methysergide—Pain—Vinorelbine—ovarian cancer	0.0022	0.00289	CcSEcCtD
Methysergide—Constipation—Vinorelbine—ovarian cancer	0.0022	0.00289	CcSEcCtD
Methysergide—Asthenia—Topotecan—ovarian cancer	0.00216	0.00284	CcSEcCtD
Methysergide—Alopecia—Paclitaxel—ovarian cancer	0.00215	0.00283	CcSEcCtD
Methysergide—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00215	0.00283	CcSEcCtD
Methysergide—Vomiting—Chlorambucil—ovarian cancer	0.00215	0.00283	CcSEcCtD
Methysergide—Feeling abnormal—Vinorelbine—ovarian cancer	0.00212	0.00279	CcSEcCtD
Methysergide—Asthenia—Melphalan—ovarian cancer	0.00211	0.00278	CcSEcCtD
Methysergide—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00211	0.00277	CcSEcCtD
Methysergide—HTR2A—testis—ovarian cancer	0.00206	0.00883	CbGeAlD
Methysergide—Diarrhoea—Topotecan—ovarian cancer	0.00206	0.00271	CcSEcCtD
Methysergide—Back pain—Paclitaxel—ovarian cancer	0.00205	0.0027	CcSEcCtD
Methysergide—Abdominal pain—Vinorelbine—ovarian cancer	0.00204	0.00268	CcSEcCtD
Methysergide—Body temperature increased—Vinorelbine—ovarian cancer	0.00204	0.00268	CcSEcCtD
Methysergide—Oedema peripheral—Docetaxel—ovarian cancer	0.00204	0.00268	CcSEcCtD
Methysergide—Diarrhoea—Melphalan—ovarian cancer	0.00202	0.00265	CcSEcCtD
Methysergide—Pain in extremity—Epirubicin—ovarian cancer	0.00201	0.00265	CcSEcCtD
Methysergide—Nausea—Chlorambucil—ovarian cancer	0.00201	0.00264	CcSEcCtD
Methysergide—Dizziness—Topotecan—ovarian cancer	0.00199	0.00262	CcSEcCtD
Methysergide—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00197	0.00259	CcSEcCtD
Methysergide—Flushing—Docetaxel—ovarian cancer	0.00192	0.00252	CcSEcCtD
Methysergide—Vomiting—Topotecan—ovarian cancer	0.00191	0.00252	CcSEcCtD
Methysergide—Malaise—Paclitaxel—ovarian cancer	0.00191	0.00252	CcSEcCtD
Methysergide—Rash—Topotecan—ovarian cancer	0.0019	0.00249	CcSEcCtD
Methysergide—Dermatitis—Topotecan—ovarian cancer	0.0019	0.00249	CcSEcCtD
Methysergide—Ataxia—Epirubicin—ovarian cancer	0.00189	0.00249	CcSEcCtD
Methysergide—Vomiting—Melphalan—ovarian cancer	0.00187	0.00246	CcSEcCtD
Methysergide—Pain in extremity—Doxorubicin—ovarian cancer	0.00186	0.00245	CcSEcCtD
Methysergide—Rash—Melphalan—ovarian cancer	0.00186	0.00244	CcSEcCtD
Methysergide—Dermatitis—Melphalan—ovarian cancer	0.00186	0.00244	CcSEcCtD
Methysergide—Asthenia—Vinorelbine—ovarian cancer	0.00185	0.00243	CcSEcCtD
Methysergide—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00184	0.00242	CcSEcCtD
Methysergide—Convulsion—Paclitaxel—ovarian cancer	0.00184	0.00242	CcSEcCtD
Methysergide—Alopecia—Docetaxel—ovarian cancer	0.00183	0.0024	CcSEcCtD
Methysergide—Chest pain—Paclitaxel—ovarian cancer	0.00181	0.00237	CcSEcCtD
Methysergide—Myalgia—Paclitaxel—ovarian cancer	0.00181	0.00237	CcSEcCtD
Methysergide—Arthralgia—Paclitaxel—ovarian cancer	0.00181	0.00237	CcSEcCtD
Methysergide—Nausea—Topotecan—ovarian cancer	0.00179	0.00235	CcSEcCtD
Methysergide—Discomfort—Paclitaxel—ovarian cancer	0.00178	0.00235	CcSEcCtD
Methysergide—Diarrhoea—Vinorelbine—ovarian cancer	0.00176	0.00232	CcSEcCtD
Methysergide—Ataxia—Doxorubicin—ovarian cancer	0.00175	0.0023	CcSEcCtD
Methysergide—Nausea—Melphalan—ovarian cancer	0.00175	0.0023	CcSEcCtD
Methysergide—Back pain—Docetaxel—ovarian cancer	0.00174	0.00229	CcSEcCtD
Methysergide—Oedema—Paclitaxel—ovarian cancer	0.00173	0.00228	CcSEcCtD
Methysergide—Eosinophilia—Epirubicin—ovarian cancer	0.00172	0.00227	CcSEcCtD
Methysergide—Dizziness—Vinorelbine—ovarian cancer	0.0017	0.00224	CcSEcCtD
Methysergide—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.0017	0.00224	CcSEcCtD
Methysergide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.0017	0.00223	CcSEcCtD
Methysergide—Tachycardia—Paclitaxel—ovarian cancer	0.00169	0.00222	CcSEcCtD
Methysergide—Vomiting—Vinorelbine—ovarian cancer	0.00164	0.00215	CcSEcCtD
Methysergide—Dysuria—Epirubicin—ovarian cancer	0.00163	0.00214	CcSEcCtD
Methysergide—Neutropenia—Epirubicin—ovarian cancer	0.00163	0.00214	CcSEcCtD
Methysergide—Rash—Vinorelbine—ovarian cancer	0.00162	0.00213	CcSEcCtD
Methysergide—Dermatitis—Vinorelbine—ovarian cancer	0.00162	0.00213	CcSEcCtD
Methysergide—Eosinophilia—Doxorubicin—ovarian cancer	0.00159	0.0021	CcSEcCtD
Methysergide—Weight increased—Epirubicin—ovarian cancer	0.00158	0.00208	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00158	0.00207	CcSEcCtD
Methysergide—Weight decreased—Epirubicin—ovarian cancer	0.00157	0.00207	CcSEcCtD
Methysergide—Insomnia—Paclitaxel—ovarian cancer	0.00157	0.00206	CcSEcCtD
Methysergide—Convulsion—Docetaxel—ovarian cancer	0.00156	0.00205	CcSEcCtD
Methysergide—Paraesthesia—Paclitaxel—ovarian cancer	0.00155	0.00204	CcSEcCtD
Methysergide—Drowsiness—Epirubicin—ovarian cancer	0.00155	0.00204	CcSEcCtD
Methysergide—Dyspnoea—Paclitaxel—ovarian cancer	0.00154	0.00203	CcSEcCtD
Methysergide—Somnolence—Paclitaxel—ovarian cancer	0.00154	0.00202	CcSEcCtD
Methysergide—Myalgia—Docetaxel—ovarian cancer	0.00153	0.00201	CcSEcCtD
Methysergide—Arthralgia—Docetaxel—ovarian cancer	0.00153	0.00201	CcSEcCtD
Methysergide—Chest pain—Docetaxel—ovarian cancer	0.00153	0.00201	CcSEcCtD
Methysergide—Nausea—Vinorelbine—ovarian cancer	0.00153	0.00201	CcSEcCtD
Methysergide—Dyspepsia—Paclitaxel—ovarian cancer	0.00152	0.002	CcSEcCtD
Methysergide—Dysuria—Doxorubicin—ovarian cancer	0.00151	0.00198	CcSEcCtD
Methysergide—Neutropenia—Doxorubicin—ovarian cancer	0.00151	0.00198	CcSEcCtD
Methysergide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00149	0.00197	CcSEcCtD
Methysergide—Fatigue—Paclitaxel—ovarian cancer	0.00149	0.00196	CcSEcCtD
Methysergide—Ergotamine—ABCB1—ovarian cancer	0.00149	0.267	CrCbGaD
Methysergide—Constipation—Paclitaxel—ovarian cancer	0.00148	0.00195	CcSEcCtD
Methysergide—Pain—Paclitaxel—ovarian cancer	0.00148	0.00195	CcSEcCtD
Methysergide—Oedema—Docetaxel—ovarian cancer	0.00147	0.00193	CcSEcCtD
Methysergide—Weight increased—Doxorubicin—ovarian cancer	0.00147	0.00193	CcSEcCtD
Methysergide—Weight decreased—Doxorubicin—ovarian cancer	0.00146	0.00192	CcSEcCtD
Methysergide—Thrombocytopenia—Docetaxel—ovarian cancer	0.00144	0.00189	CcSEcCtD
Methysergide—Drowsiness—Doxorubicin—ovarian cancer	0.00144	0.00189	CcSEcCtD
Methysergide—Bromocriptine—ABCB1—ovarian cancer	0.00143	0.258	CrCbGaD
Methysergide—Tachycardia—Docetaxel—ovarian cancer	0.00143	0.00188	CcSEcCtD
Methysergide—Feeling abnormal—Paclitaxel—ovarian cancer	0.00143	0.00188	CcSEcCtD
Methysergide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00142	0.00186	CcSEcCtD
Methysergide—Oedema peripheral—Epirubicin—ovarian cancer	0.00137	0.0018	CcSEcCtD
Methysergide—Abdominal pain—Paclitaxel—ovarian cancer	0.00137	0.0018	CcSEcCtD
Methysergide—Body temperature increased—Paclitaxel—ovarian cancer	0.00137	0.0018	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00134	0.00176	CcSEcCtD
Methysergide—Insomnia—Docetaxel—ovarian cancer	0.00133	0.00175	CcSEcCtD
Methysergide—Paraesthesia—Docetaxel—ovarian cancer	0.00132	0.00173	CcSEcCtD
Methysergide—Dyspnoea—Docetaxel—ovarian cancer	0.00131	0.00172	CcSEcCtD
Methysergide—Somnolence—Docetaxel—ovarian cancer	0.0013	0.00172	CcSEcCtD
Methysergide—Flushing—Epirubicin—ovarian cancer	0.00129	0.0017	CcSEcCtD
Methysergide—Dyspepsia—Docetaxel—ovarian cancer	0.00129	0.0017	CcSEcCtD
Methysergide—Oedema peripheral—Doxorubicin—ovarian cancer	0.00127	0.00167	CcSEcCtD
Methysergide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00127	0.00167	CcSEcCtD
Methysergide—Fatigue—Docetaxel—ovarian cancer	0.00127	0.00166	CcSEcCtD
Methysergide—Constipation—Docetaxel—ovarian cancer	0.00126	0.00165	CcSEcCtD
Methysergide—Pain—Docetaxel—ovarian cancer	0.00126	0.00165	CcSEcCtD
Methysergide—Asthenia—Paclitaxel—ovarian cancer	0.00124	0.00163	CcSEcCtD
Methysergide—Alopecia—Epirubicin—ovarian cancer	0.00123	0.00162	CcSEcCtD
Methysergide—Feeling abnormal—Docetaxel—ovarian cancer	0.00121	0.00159	CcSEcCtD
Methysergide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.0012	0.00158	CcSEcCtD
Methysergide—Flushing—Doxorubicin—ovarian cancer	0.0012	0.00157	CcSEcCtD
Methysergide—Diarrhoea—Paclitaxel—ovarian cancer	0.00118	0.00156	CcSEcCtD
Methysergide—Back pain—Epirubicin—ovarian cancer	0.00117	0.00154	CcSEcCtD
Methysergide—Body temperature increased—Docetaxel—ovarian cancer	0.00116	0.00153	CcSEcCtD
Methysergide—Abdominal pain—Docetaxel—ovarian cancer	0.00116	0.00153	CcSEcCtD
Methysergide—Dizziness—Paclitaxel—ovarian cancer	0.00115	0.00151	CcSEcCtD
Methysergide—Alopecia—Doxorubicin—ovarian cancer	0.00114	0.0015	CcSEcCtD
Methysergide—Ill-defined disorder—Epirubicin—ovarian cancer	0.00113	0.00148	CcSEcCtD
Methysergide—Vomiting—Paclitaxel—ovarian cancer	0.0011	0.00145	CcSEcCtD
Methysergide—Malaise—Epirubicin—ovarian cancer	0.00109	0.00144	CcSEcCtD
Methysergide—Rash—Paclitaxel—ovarian cancer	0.00109	0.00144	CcSEcCtD
Methysergide—Dermatitis—Paclitaxel—ovarian cancer	0.00109	0.00143	CcSEcCtD
Methysergide—Back pain—Doxorubicin—ovarian cancer	0.00109	0.00143	CcSEcCtD
Methysergide—Asthenia—Docetaxel—ovarian cancer	0.00105	0.00138	CcSEcCtD
Methysergide—Convulsion—Epirubicin—ovarian cancer	0.00105	0.00138	CcSEcCtD
Methysergide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00104	0.00137	CcSEcCtD
Methysergide—Chest pain—Epirubicin—ovarian cancer	0.00103	0.00136	CcSEcCtD
Methysergide—Myalgia—Epirubicin—ovarian cancer	0.00103	0.00136	CcSEcCtD
Methysergide—Arthralgia—Epirubicin—ovarian cancer	0.00103	0.00136	CcSEcCtD
Methysergide—Nausea—Paclitaxel—ovarian cancer	0.00103	0.00135	CcSEcCtD
Methysergide—Discomfort—Epirubicin—ovarian cancer	0.00102	0.00134	CcSEcCtD
Methysergide—Malaise—Doxorubicin—ovarian cancer	0.00101	0.00133	CcSEcCtD
Methysergide—Diarrhoea—Docetaxel—ovarian cancer	0.001	0.00132	CcSEcCtD
Methysergide—Oedema—Epirubicin—ovarian cancer	0.00099	0.0013	CcSEcCtD
Methysergide—Convulsion—Doxorubicin—ovarian cancer	0.000972	0.00128	CcSEcCtD
Methysergide—Dizziness—Docetaxel—ovarian cancer	0.000971	0.00128	CcSEcCtD
Methysergide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000969	0.00127	CcSEcCtD
Methysergide—Tachycardia—Epirubicin—ovarian cancer	0.000966	0.00127	CcSEcCtD
Methysergide—Chest pain—Doxorubicin—ovarian cancer	0.000956	0.00126	CcSEcCtD
Methysergide—Arthralgia—Doxorubicin—ovarian cancer	0.000956	0.00126	CcSEcCtD
Methysergide—Myalgia—Doxorubicin—ovarian cancer	0.000956	0.00126	CcSEcCtD
Methysergide—Discomfort—Doxorubicin—ovarian cancer	0.000944	0.00124	CcSEcCtD
Methysergide—Vomiting—Docetaxel—ovarian cancer	0.000933	0.00123	CcSEcCtD
Methysergide—Rash—Docetaxel—ovarian cancer	0.000925	0.00122	CcSEcCtD
Methysergide—Dermatitis—Docetaxel—ovarian cancer	0.000925	0.00122	CcSEcCtD
Methysergide—Oedema—Doxorubicin—ovarian cancer	0.000916	0.0012	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000902	0.00119	CcSEcCtD
Methysergide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000897	0.00118	CcSEcCtD
Methysergide—Insomnia—Epirubicin—ovarian cancer	0.000895	0.00118	CcSEcCtD
Methysergide—Tachycardia—Doxorubicin—ovarian cancer	0.000894	0.00118	CcSEcCtD
Methysergide—Paraesthesia—Epirubicin—ovarian cancer	0.000889	0.00117	CcSEcCtD
Methysergide—Dyspnoea—Epirubicin—ovarian cancer	0.000883	0.00116	CcSEcCtD
Methysergide—Somnolence—Epirubicin—ovarian cancer	0.00088	0.00116	CcSEcCtD
Methysergide—Nausea—Docetaxel—ovarian cancer	0.000872	0.00115	CcSEcCtD
Methysergide—Dyspepsia—Epirubicin—ovarian cancer	0.000871	0.00115	CcSEcCtD
Methysergide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000855	0.00112	CcSEcCtD
Methysergide—Fatigue—Epirubicin—ovarian cancer	0.000853	0.00112	CcSEcCtD
Methysergide—Pain—Epirubicin—ovarian cancer	0.000847	0.00111	CcSEcCtD
Methysergide—Constipation—Epirubicin—ovarian cancer	0.000847	0.00111	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000835	0.0011	CcSEcCtD
Methysergide—Insomnia—Doxorubicin—ovarian cancer	0.000828	0.00109	CcSEcCtD
Methysergide—Paraesthesia—Doxorubicin—ovarian cancer	0.000823	0.00108	CcSEcCtD
Methysergide—Dyspnoea—Doxorubicin—ovarian cancer	0.000817	0.00107	CcSEcCtD
Methysergide—Feeling abnormal—Epirubicin—ovarian cancer	0.000816	0.00107	CcSEcCtD
Methysergide—Somnolence—Doxorubicin—ovarian cancer	0.000814	0.00107	CcSEcCtD
Methysergide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00081	0.00106	CcSEcCtD
Methysergide—Dyspepsia—Doxorubicin—ovarian cancer	0.000806	0.00106	CcSEcCtD
Methysergide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000791	0.00104	CcSEcCtD
Methysergide—Fatigue—Doxorubicin—ovarian cancer	0.00079	0.00104	CcSEcCtD
Methysergide—Constipation—Doxorubicin—ovarian cancer	0.000783	0.00103	CcSEcCtD
Methysergide—Pain—Doxorubicin—ovarian cancer	0.000783	0.00103	CcSEcCtD
Methysergide—Abdominal pain—Epirubicin—ovarian cancer	0.000783	0.00103	CcSEcCtD
Methysergide—Body temperature increased—Epirubicin—ovarian cancer	0.000783	0.00103	CcSEcCtD
Methysergide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000755	0.000992	CcSEcCtD
Methysergide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000749	0.000985	CcSEcCtD
Methysergide—Abdominal pain—Doxorubicin—ovarian cancer	0.000724	0.000952	CcSEcCtD
Methysergide—Body temperature increased—Doxorubicin—ovarian cancer	0.000724	0.000952	CcSEcCtD
Methysergide—Asthenia—Epirubicin—ovarian cancer	0.00071	0.000934	CcSEcCtD
Methysergide—Diarrhoea—Epirubicin—ovarian cancer	0.000677	0.00089	CcSEcCtD
Methysergide—Asthenia—Doxorubicin—ovarian cancer	0.000657	0.000864	CcSEcCtD
Methysergide—Dizziness—Epirubicin—ovarian cancer	0.000655	0.000861	CcSEcCtD
Methysergide—Vomiting—Epirubicin—ovarian cancer	0.000629	0.000827	CcSEcCtD
Methysergide—Diarrhoea—Doxorubicin—ovarian cancer	0.000627	0.000824	CcSEcCtD
Methysergide—Rash—Epirubicin—ovarian cancer	0.000624	0.000821	CcSEcCtD
Methysergide—Dermatitis—Epirubicin—ovarian cancer	0.000624	0.00082	CcSEcCtD
Methysergide—Dizziness—Doxorubicin—ovarian cancer	0.000606	0.000796	CcSEcCtD
Methysergide—Nausea—Epirubicin—ovarian cancer	0.000588	0.000773	CcSEcCtD
Methysergide—Vomiting—Doxorubicin—ovarian cancer	0.000582	0.000766	CcSEcCtD
Methysergide—Rash—Doxorubicin—ovarian cancer	0.000578	0.000759	CcSEcCtD
Methysergide—Dermatitis—Doxorubicin—ovarian cancer	0.000577	0.000759	CcSEcCtD
Methysergide—Nausea—Doxorubicin—ovarian cancer	0.000544	0.000715	CcSEcCtD
